The potential therapeutic effects of salidroside on erectile dysfunction associated with diabetes are speculated to be achieved by increasing the activity of the Nrf2/HO-1 signalling pathway, which in turn reduces oxidative stress levels in the tissue of the penile corpus cavernosum, decreases cell apoptosis, and alleviates fibrosis [7]. The gene discussed is NFE2L2; the disease is diabetes mellitus.